As of 2025-05-17, the Net Margin of DaShenLin Pharmaceutical Group Co Ltd (603233.SS) is 3.5%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
Date | Value |
---|---|
2024-12-31 | 3.5% |
2023-12-31 | 4.8% |
2022-12-31 | 4.9% |
2021-12-31 | 4.7% |
2020-12-31 | 7.3% |
2019-12-31 | 6.3% |
2018-12-31 | 6% |
2017-12-31 | 6.4% |
2016-12-31 | 6.9% |
2015-12-31 | 7.5% |